Autosomal recessive primary microcephaly
diseaseOn this page
Also known as MCPHmicrocephalia veramicrocephaly veramicrocephaly, primary autosomal recessivemicrocephaly, primary, autosomal recessivetrue microcephaly
Summary
Autosomal recessive primary microcephaly (MONDO:0016660) is a disease (an umbrella term covering 29 Mondo subtypes) caused by variants in ASPM, KIF14, and STIL, with 27 cohort genes. The dominant Reactome pathway is Loss of Nlp from mitotic centrosomes (5 cohort genes).
At a glance
- Prevalence: 1-9 / 1 000 000 (Specific population) [Orphanet-validated]
- Causal genes: ASPM (GenCC Definitive), KIF14 (GenCC Definitive), STIL (GenCC Definitive)
- Umbrella term: 29 Mondo subtypes
- Cohort genes: 27
- ClinVar variants: 45
- Phenotypes (HPO): 17
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Annual incidence | 1-9 / 1 000 000 | 0.1 | Specific population | Validated |
| Annual incidence | 1-9 / 100 000 | 1 | Pakistan | Validated |
Signs & symptoms
Clinical features (HPO)
17 HPO clinical features (Orphanet curated; top 17 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000219 | Thin upper lip vermilion | Very frequent (80-99%) |
| HP:0000252 | Microcephaly | Very frequent (80-99%) |
| HP:0000340 | Sloping forehead | Very frequent (80-99%) |
| HP:0000582 | Upslanted palpebral fissure | Very frequent (80-99%) |
| HP:0001263 | Global developmental delay | Very frequent (80-99%) |
| HP:0001510 | Growth delay | Very frequent (80-99%) |
| HP:0002282 | Gray matter heterotopia | Very frequent (80-99%) |
| HP:0004322 | Short stature | Very frequent (80-99%) |
| HP:0010864 | Intellectual disability, severe | Very frequent (80-99%) |
| HP:0000076 | Vesicoureteral reflux | Frequent (30-79%) |
| HP:0000122 | Unilateral renal agenesis | Frequent (30-79%) |
| HP:0001274 | Agenesis of corpus callosum | Frequent (30-79%) |
| HP:0001302 | Pachygyria | Frequent (30-79%) |
| HP:0001347 | Hyperreflexia | Frequent (30-79%) |
| HP:0002119 | Ventriculomegaly | Frequent (30-79%) |
| HP:0003103 | Abnormal cortical bone morphology | Frequent (30-79%) |
| HP:0007333 | Hypoplasia of the frontal lobes | Frequent (30-79%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | autosomal recessive primary microcephaly |
| Mondo ID | MONDO:0016660 |
| MeSH | C579935 |
| OMIM | 251200 |
| Orphanet | 2512 |
| DOID | DOID:0070296 |
| SNOMED CT | 715981004 |
| UMLS | C3711387 |
| MedGen | 777995 |
| GARD | 0012117 |
| Is cancer (heuristic) | no |
Also known as: MCPH · microcephalia vera · microcephaly vera · microcephaly, primary autosomal recessive · microcephaly, primary, autosomal recessive · true microcephaly
Data availability: 45 ClinVar variants · 27 GenCC gene-disease records.
Disease family
An umbrella term covering 29 Mondo subtypes.
Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › autosomal genetic disease › autosomal recessive disease › autosomal recessive primary microcephaly
Related subtypes (218): immunodeficiency-centromeric instability-facial anomalies syndrome, hypercalcemia, infantile, Ochoa syndrome, autosomal recessive Ehlers-Danlos syndrome, vascular type, hydrolethalus syndrome, 3-M syndrome, isolated hyperchlorhidrosis, dacryocystitis-osteopoikilosis syndrome, Hutchinson-Gilford progeria syndrome, achalasia microcephaly syndrome, acrorenal syndrome, autosomal recessive, beta-ketothiolase deficiency, autosomal recessive Alport syndrome, Alstrom syndrome, microphthalmia with limb anomalies, camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Behr syndrome, bifid nose, autosomal recessive, Bloom syndrome, Bowen-Conradi syndrome, camptodactyly with fibrous tissue hyperplasia and skeletal dysplasia, heart defects-limb shortening syndrome, autosomal recessive palmoplantar keratoderma and congenital alopecia, COFS syndrome, craniometaphyseal dysplasia, autosomal recessive, Fraser syndrome, cystic fibrosis, polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly, persistent hyperplastic primary vitreous, autosomal recessive, Donnai-Barrow syndrome, Schöpf-Schulz-Passarge syndrome, cleft lip/palate-ectodermal dysplasia syndrome, Ellis-van Creveld syndrome, Wolcott-Rallison syndrome, autosomal recessive faciodigitogenital syndrome, acromesomelic dysplasia 2B, brittle cornea syndrome, triple-A syndrome, autosomal recessive humeroradial synostosis, multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome, hydrocephalus, nonsyndromic, autosomal recessive 1, autosomal recessive hydrocephalus due to congenital stenosis of aqueduct of Sylvius, hypertelorism, microtia, facial clefting syndrome, hypoparathyroidism-retardation-dysmorphism syndrome, Vici syndrome, Johanson-Blizzard syndrome, autosomal recessive Kenny-Caffey syndrome, Papillon-Lefevre disease, Haim-Munk syndrome, Laurence-Moon syndrome, Donohue syndrome, lipase deficiency, combined, autosomal recessive familial Mediterranean fever, thiamine-responsive megaloblastic anemia syndrome, cartilage-hair hypoplasia, Nijmegen breakage syndrome, pseudo-TORCH syndrome, Galloway-Mowat syndrome, mulibrey nanism, myotonia congenita, autosomal recessive, Schwartz-Jampel syndrome, proteosome-associated autoinflammatory syndrome, Netherton syndrome, Niemann-Pick disease type A, oculodentodigital dysplasia, autosomal recessive, odonto-onycho-dermal dysplasia, autosomal recessive omodysplasia, osteoporosis-pseudoglioma syndrome, Shwachman-Diamond syndrome, phenylketonuria, Bjornstad syndrome, Laron syndrome, autosomal recessive polycystic kidney disease, autosomal recessive inherited pseudoxanthoma elasticum, autosomal recessive multiple pterygium syndrome, rapadilino syndrome, short-rib thoracic dysplasia 9 with or without polydactyly, autosomal recessive Robinow syndrome, Sjogren-Larsson syndrome, scapuloperoneal spinal muscular atrophy, autosomal recessive, spondyloepiphyseal dysplasia tarda, autosomal recessive, inherited threoninemia, Pendred syndrome, autosomal recessive spondylocostal dysostosis, Werner syndrome, ABCD syndrome, Naxos disease, autosomal recessive amelia, human HOXA1 syndromes, sickle cell disease, autosomal recessive proximal renal tubular acidosis, hyper-IgM syndrome type 2, temtamy preaxial brachydactyly syndrome, TH-deficient dopa-responsive dystonia, craniosynostosis syndrome, autosomal recessive, Niemann-Pick disease type B, skin fragility-woolly hair-palmoplantar keratoderma syndrome, CoQ-responsive OXPHOS deficiency, familial adenomatous polyposis 2, Pierson syndrome, palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome, cardiomyopathy-hypotonia-lactic acidosis syndrome, PHARC syndrome, Kahrizi syndrome, cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies, congenital prothrombin deficiency, immunodeficiency 31B, dyskeratosis congenita, autosomal recessive 2, dyskeratosis congenita, autosomal recessive 3, Nestor-Guillermo progeria syndrome, leukoencephalopathy with calcifications and cysts, mitochondrial pyruvate carrier deficiency, branched-chain keto acid dehydrogenase kinase deficiency, dyskeratosis congenita, autosomal recessive 5, hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome, alacrima, achalasia, and intellectual disability syndrome, hyperlipoproteinemia, type 1D, microcephaly and chorioretinopathy 2, congenital stationary night blindness 1G, combined oxidative phosphorylation deficiency 29, hypermanganesemia with dystonia 2, growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy, gnb5-related intellectual disability-cardiac arrhythmia syndrome, autosomal recessive spastic paraplegia type 78, autosomal recessive limb-girdle muscular dystrophy, Bardet-Biedl syndrome, autosomal recessive cerebellar ataxia, neuronopathy, distal hereditary motor, autosomal recessive, UV-sensitive syndrome, Ehlers-Danlos syndrome, kyphoscoliotic type 1, Cockayne syndrome, hyperphenylalaninemia due to tetrahydrobiopterin deficiency, leukoencephalopathy-palmoplantar keratoderma syndrome, autosomal recessive hypohidrotic ectodermal dysplasia, Warburg micro syndrome, autosomal recessive progressive external ophthalmoplegia, Meier-Gorlin syndrome, autosomal recessive sideroblastic anemia, autosomal recessive intermediate Charcot-Marie-Tooth disease, Perrault syndrome, autosomal recessive hypophosphatemic rickets, de Barsy syndrome, leukocyte adhesion deficiency, Senior-Loken syndrome, autosomal recessive spastic ataxia, childhood-onset autosomal recessive myopathy with external ophthalmoplegia, autosomal recessive cerebral atrophy, GM3 synthase deficiency, autosomal recessive distal renal tubular acidosis, pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome, autosomal recessive brachyolmia, Aicardi-Goutieres syndrome, homocystinuria without methylmalonic aciduria, Niemann-Pick disease type C, nephronophthisis, autosomal recessive osteopetrosis, peroxisome biogenesis disorder, congenital non-bullous ichthyosiform erythroderma, Seckel syndrome, Usher syndrome, autosomal recessive cutis laxa type 1, autosomal recessive cutis laxa type 2, hearing loss, autosomal recessive, microcephaly, growth restriction, and increased sister chromatid exchange 2, encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1, congenital vertebral-cardiac-renal anomalies syndrome, hair defect with photosensitivity and intellectual disability syndrome, autosomal recessive severe congenital neutropenia, severe combined immunodeficiency due to CARMIL2 deficiency, extraoral halitosis due to methanethiol oxidase deficiency, neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, mitochondrial complex 2 deficiency, nuclear type 3, mitochondrial complex 2 deficiency, nuclear type 4, mismatch repair cancer syndrome, spondyloepimetaphyseal dysplasia with joint laxity, type 3, Kilquist syndrome, Duane anomaly-myopathy-scoliosis syndrome, autosomal recessive axonal charcot-marie-tooth disease due to copper metabolism defect, immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome, optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome, congenital myopathy with reduced type 2 muscle fibers, NAD(P)HX dehydratase deficiency, autosomal recessive ocular albinism, ichthyosis linearis circumflexa, eosinophil peroxidase deficiency, hyperphenylalaninemia due to DNAJC12 deficiency, autosomal recessive epidermolytic ichthyosis, Ehlers-Danlos syndrome, classic-like, 2, joint laxity, short stature, and myopia, HELIX syndrome, auditory neuropathy-optic atrophy syndrome, glycosylphosphatidylinositol biosynthesis defect 15, neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures, SCN4A-related myopathy, autosomal recessive, Uner Tan Syndrome, nephropathic cystinosis, Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome type 2, permanent neonatal diabetes mellitus 1, growth hormone insensitivity with immune dysregulation 1, autosomal recessive, Rajab interstitial lung disease with brain calcifications 1, Roberts-SC phocomelia syndrome, neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, RPE65-related recessive retinopathy, GUCY2D-related recessive retinopathy, autosomal recessive titinopathy, intellectual disability, autosomal recessive, ALPL-related autosomal recessive hypophosphatasia, spastic paraplegia 18b, autosomal recessive, CEP164-related ciliopathy, RP1-related recessive retinopathy, pseudohypoaldosteronism, type IB2, autosomal recessive, pseudohypoaldosteronism, type IB3, autosomal recessive, spastic paraplegia 30B, autosomal recessive, cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1, brain small vessel disease 2B, autosomal recessive, IMPG1-related recessive retinopathy, PROM1-related recessive retinopathy
Subtypes (29): microcephaly 1, primary, autosomal recessive, microcephaly with simplified gyral pattern, microcephaly 2, primary, autosomal recessive, with or without cortical malformations, microcephaly 4, primary, autosomal recessive, microcephaly 3, primary, autosomal recessive, microcephaly 5, primary, autosomal recessive, microcephaly 7, primary, autosomal recessive, microcephaly 8, primary, autosomal recessive, microcephaly 9, primary, autosomal recessive, microcephalic primordial dwarfism due to ZNF335 deficiency, microcephaly 11, primary, autosomal recessive, microcephaly 13, primary, autosomal recessive, microcephaly 12, primary, autosomal recessive, microcephaly 14, primary, autosomal recessive, microcephaly 15, primary, autosomal recessive, microcephaly 16, primary, autosomal recessive, microcephaly 17, primary, autosomal recessive, microcephaly 28, primary, autosomal recessive, microcephaly 29, primary, autosomal recessive, microcephaly 24, primary, autosomal recessive, microcephaly 25, primary, autosomal recessive, microcephaly 19, primary, autosomal recessive, microcephaly 20, primary, autosomal recessive, microcephaly 21, primary, autosomal recessive, microcephaly 22, primary, autosomal recessive, microcephaly 23, primary, autosomal recessive, microcephaly with or without short stature, microcephaly 30, primary, autosomal recessive, microcephaly 31, primary, autosomal recessive
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
45 retrieved; paginated sample, class counts are floors:
25 pathogenic, 9 likely pathogenic, 5 pathogenic/likely pathogenic, 3 uncertain significance, 3 conflicting classifications of pathogenicity
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 4688532 | NC_000008.10:g.(6264211_6266799)_(6357451_6478974)del | ANGPT2 | Pathogenic | criteria provided, single submitter |
| 4688536 | NC_000008.10:g.(?6264147)(6357451_6478974)del | ANGPT2 | Pathogenic | criteria provided, single submitter |
| 157795 | NM_018136.5(ASPM):c.2419+2T>C | ASPM | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 157867 | NM_018136.5(ASPM):c.7160_7161del (p.Ser2387fs) | ASPM | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 21582 | NM_018136.5(ASPM):c.3796G>T (p.Glu1266Ter) | ASPM | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 2581671 | NM_018136.5(ASPM):c.8195_8196del (p.Arg2732fs) | ASPM | Pathogenic | criteria provided, single submitter |
| 3384969 | NM_018136.5(ASPM):c.6107_6110del (p.Val2036fs) | ASPM | Pathogenic | criteria provided, single submitter |
| 3600659 | NM_018136.5(ASPM):c.5505del (p.Phe1835fs) | ASPM | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 3902244 | NM_018136.5(ASPM):c.3483_3484del (p.Ile1161fs) | ASPM | Pathogenic | criteria provided, single submitter |
| 3902257 | NM_018136.5(ASPM):c.1480del (p.Ser494fs) | ASPM | Pathogenic | criteria provided, single submitter |
| 432552 | NM_018136.5(ASPM):c.1697C>A (p.Ser566Ter) | ASPM | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 4687500 | NM_018136.5(ASPM):c.4598_4601del (p.Asn1533fs) | ASPM | Pathogenic | criteria provided, single submitter |
| 4960 | NM_018136.5(ASPM):c.9178C>T (p.Gln3060Ter) | ASPM | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 631585 | NM_018136.5(ASPM):c.4849C>T (p.Arg1617Ter) | ASPM | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 252992 | NM_001206999.2(CIT):c.1111+1G>A | CIT | Pathogenic | criteria provided, single submitter |
| 252993 | NM_001206999.2(CIT):c.412C>T (p.Gln138Ter) | CIT | Pathogenic | no assertion criteria provided |
| 252994 | NM_001206999.2(CIT):c.473C>G (p.Pro158Arg) | CIT | Pathogenic | no assertion criteria provided |
| 210670 | NM_018451.5(CPAP):c.898_899del (p.Glu300fs) | CPAP | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 158830 | NM_024596.5(MCPH1):c.1869_1870del (p.Ser623_Cys624insTer) | MCPH1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2691298 | NM_024596.5(MCPH1):c.698C>A (p.Ser233Ter) | MCPH1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 2826934 | NM_024596.5(MCPH1):c.595C>T (p.Gln199Ter) | MCPH1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 30641 | NM_024596.5(MCPH1):c.215C>T (p.Ser72Leu) | MCPH1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 3902579 | NM_024596.5(MCPH1):c.2312del (p.Pro771fs) | MCPH1 | Pathogenic | criteria provided, single submitter |
| 4847425 | NM_024596.5(MCPH1):c.2021C>G (p.Ser674Ter) | MCPH1 | Pathogenic | criteria provided, single submitter |
| 4847982 | NC_000008.10:g.(?6264147)(6293684_6296473)del | MCPH1 | Pathogenic | criteria provided, single submitter |
| 4848157 | NM_024596.5(MCPH1):c.1341_1344del (p.Ser448fs) | MCPH1 | Pathogenic | criteria provided, single submitter |
| 2581189 | NM_024596.5(MCPH1):c.2404G>T (p.Gly802Ter) | MCPH1-AS1 | Pathogenic | criteria provided, single submitter |
| 31037 | NM_001083961.2(WDR62):c.1531G>A (p.Asp511Asn) | WDR62 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 3336245 | NC_000019.9:g.(36564434_36572334)_(36575647_36577588)del | WDR62 | Pathogenic | criteria provided, single submitter |
| 3896394 | NC_000019.9:g.(36550933_36556859)_(36564434_36572334)del | WDR62 | Pathogenic | criteria provided, single submitter |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 108 · Orphanet: 35 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| ASPM | Definitive | Autosomal recessive | autosomal recessive primary microcephaly | 5 |
| CPAP | Definitive | Autosomal recessive | microcephaly 6 with or without short stature | 5 |
| KIF14 | Definitive | Autosomal recessive | autosomal recessive primary microcephaly | 7 |
| MCPH1 | Definitive | Autosomal recessive | microcephaly 1, primary, autosomal recessive | 6 |
| MFSD2A | Definitive | Autosomal recessive | microcephaly 15, primary, autosomal recessive | 4 |
| STIL | Definitive | Autosomal recessive | autosomal recessive primary microcephaly | 6 |
| WDR62 | Definitive | Autosomal recessive | microcephaly 2, primary, autosomal recessive, with or without cortical malformations | 8 |
| ANKLE2 | Strong | Autosomal recessive | microcephaly 16, primary, autosomal recessive | 4 |
| CDK5RAP2 | Strong | Autosomal recessive | microcephaly 3, primary, autosomal recessive | 5 |
| CEP135 | Strong | Autosomal recessive | microcephaly 8, primary, autosomal recessive | 3 |
| CEP152 | Strong | Autosomal recessive | microcephaly 9, primary, autosomal recessive | 4 |
| CIT | Strong | Autosomal recessive | microcephaly 17, primary, autosomal recessive | 4 |
| KNL1 | Strong | Autosomal recessive | microcephaly 4, primary, autosomal recessive | 4 |
| SASS6 | Strong | Autosomal recessive | microcephaly 14, primary, autosomal recessive | 5 |
| NCAPD3 | Moderate | Autosomal recessive | microcephaly 22, primary, autosomal recessive | 3 |
| PHC1 | Moderate | Autosomal recessive | microcephaly 11, primary, autosomal recessive | 4 |
| CDK6 | Supportive | Autosomal recessive | autosomal recessive primary microcephaly | 2 |
| CEP63 | Supportive | Autosomal recessive | autosomal recessive primary microcephaly | 4 |
| COPB2 | Supportive | Autosomal recessive | autosomal recessive primary microcephaly | 7 |
| METTL5 | Supportive | Autosomal recessive | autosomal recessive primary microcephaly | 5 |
| PYCR2 | Supportive | Autosomal recessive | autosomal recessive primary microcephaly | 5 |
| TAF13 | Supportive | Autosomal recessive | autosomal recessive primary microcephaly | 5 |
| TRAPPC14 | Supportive | Autosomal recessive | autosomal recessive primary microcephaly | |
| TEDC1 | Limited | Autosomal recessive | microcephaly | 2 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| TAF13 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| CPAP | Orphanet:2512 | Autosomal recessive primary microcephaly |
| CPAP | Orphanet:808 | Seckel syndrome |
| ASPM | Orphanet:2512 | Autosomal recessive primary microcephaly |
| CIT | Orphanet:2512 | Autosomal recessive primary microcephaly |
| WDR62 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| MCPH1 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| STIL | Orphanet:220386 | Semilobar holoprosencephaly |
| STIL | Orphanet:2512 | Autosomal recessive primary microcephaly |
| STIL | Orphanet:280195 | Septopreoptic holoprosencephaly |
| STIL | Orphanet:93924 | Lobar holoprosencephaly |
| STIL | Orphanet:93925 | Alobar holoprosencephaly |
| STIL | Orphanet:93926 | Midline interhemispheric variant of holoprosencephaly |
| STIL | Orphanet:99861 | Precursor T-cell acute lymphoblastic leukemia |
| CDK6 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| CDK5RAP2 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| KIF14 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| KIF14 | Orphanet:439897 | Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome |
| COPB2 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| KNL1 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| METTL5 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| SASS6 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| TRAPPC14 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| CEP63 | Orphanet:808 | Seckel syndrome |
| MFSD2A | Orphanet:2512 | Autosomal recessive primary microcephaly |
| NCAPD3 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| CEP135 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| ANKLE2 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| CEP152 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| CEP152 | Orphanet:808 | Seckel syndrome |
| PYCR2 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| PYCR2 | Orphanet:481152 | PYCR2-related microcephaly-progressive leukoencephalopathy |
| PHC1 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| ZNF335 | Orphanet:329228 | Microcephalic primordial dwarfism due to ZNF335 deficiency |
| ANGPT2 | Orphanet:363999 | Non-immune hydrops fetalis |
Cohort genes → proteins
27 cohort genes, 26 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 27 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| TAF13 | HGNC:11546 | ENSG00000197780 | Q15543 | Transcription initiation factor TFIID subunit 13 | gencc,clinvar |
| CPAP | HGNC:17272 | ENSG00000151849 | Q9HC77 | Centrosomal P4.1-associated protein | gencc,clinvar |
| ASPM | HGNC:19048 | ENSG00000066279 | Q8IZT6 | Abnormal spindle-like microcephaly-associated protein | gencc,clinvar |
| CIT | HGNC:1985 | ENSG00000122966 | O14578 | Citron Rho-interacting kinase | gencc,clinvar |
| WDR62 | HGNC:24502 | ENSG00000075702 | O43379 | WD repeat-containing protein 62 | gencc,clinvar |
| MCPH1 | HGNC:6954 | ENSG00000147316 | Q8NEM0 | Microcephalin | gencc,clinvar |
| STIL | HGNC:10879 | ENSG00000123473 | Q15468 | SCL-interrupting locus protein | gencc |
| CDK6 | HGNC:1777 | ENSG00000105810 | Q00534 | Cyclin-dependent kinase 6 | gencc |
| CDK5RAP2 | HGNC:18672 | ENSG00000136861 | Q96SN8 | CDK5 regulatory subunit-associated protein 2 | gencc |
| KIF14 | HGNC:19181 | ENSG00000118193 | Q15058 | Kinesin-like protein KIF14 | gencc |
| TEDC1 | HGNC:20127 | ENSG00000185347 | Q86SX3 | Tubulin epsilon and delta complex protein 1 | gencc |
| COPB2 | HGNC:2232 | ENSG00000184432 | P35606 | Coatomer subunit beta' | gencc |
| KNL1 | HGNC:24054 | ENSG00000137812 | Q8NG31 | Outer kinetochore KNL1 complex subunit KNL1 | gencc |
| METTL5 | HGNC:25006 | ENSG00000138382 | Q9NRN9 | rRNA N(6)-adenosine-methyltransferase METTL5 | gencc |
| SASS6 | HGNC:25403 | ENSG00000156876 | Q6UVJ0 | Spindle assembly abnormal protein 6 homolog | gencc |
| TRAPPC14 | HGNC:25604 | ENSG00000146826 | Q8WVR3 | Trafficking protein particle complex subunit 14 | gencc |
| CEP63 | HGNC:25815 | ENSG00000182923 | Q96MT8 | Centrosomal protein of 63 kDa | gencc |
| MFSD2A | HGNC:25897 | ENSG00000168389 | Q8NA29 | Sodium-dependent lysophosphatidylcholine symporter 1 | gencc |
| NCAPD3 | HGNC:28952 | ENSG00000151503 | P42695 | Condensin-2 complex subunit D3 | gencc |
| CEP135 | HGNC:29086 | ENSG00000174799 | Q66GS9 | Centrosomal protein of 135 kDa | gencc |
| ANKLE2 | HGNC:29101 | ENSG00000176915 | Q86XL3 | Ankyrin repeat and LEM domain-containing protein 2 | gencc |
| CEP152 | HGNC:29298 | ENSG00000103995 | O94986 | Centrosomal protein of 152 kDa | gencc |
| PYCR2 | HGNC:30262 | ENSG00000143811 | Q96C36 | Pyrroline-5-carboxylate reductase 2 | gencc |
| PHC1 | HGNC:3182 | ENSG00000111752 | P78364 | Polyhomeotic-like protein 1 | gencc |
| ZNF335 | HGNC:15807 | ENSG00000198026 | Q9H4Z2 | Zinc finger protein 335 | clinvar |
| ANGPT2 | HGNC:485 | ENSG00000091879 | O15123 | Angiopoietin-2 | clinvar |
| MCPH1-AS1 | HGNC:51655 | ENSG00000249898 | MCPH1 antisense RNA 1 | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| TAF13 | Transcription initiation factor TFIID subunit 13 | The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription. |
| CPAP | Centrosomal P4.1-associated protein | Plays an important role in cell division and centrosome function by participating in centriole duplication. |
| ASPM | Abnormal spindle-like microcephaly-associated protein | Involved in mitotic spindle regulation and coordination of mitotic processes. |
| CIT | Citron Rho-interacting kinase | Plays a role in cytokinesis. |
| WDR62 | WD repeat-containing protein 62 | Required for cerebral cortical development. |
| MCPH1 | Microcephalin | Implicated in chromosome condensation and DNA damage induced cellular responses. |
| STIL | SCL-interrupting locus protein | Immediate-early gene. |
| CDK6 | Cyclin-dependent kinase 6 | Serine/threonine-protein kinase involved in the control of the cell cycle and differentiation; promotes G1/S transition. |
| CDK5RAP2 | CDK5 regulatory subunit-associated protein 2 | Potential regulator of CDK5 activity via its interaction with CDK5R1. |
| KIF14 | Kinesin-like protein KIF14 | Microtubule motor protein that binds to microtubules with high affinity through each tubulin heterodimer and has an ATPase activity. |
| TEDC1 | Tubulin epsilon and delta complex protein 1 | Acts as a positive regulator of ciliary hedgehog signaling. |
| COPB2 | Coatomer subunit beta' | The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Go… |
| KNL1 | Outer kinetochore KNL1 complex subunit KNL1 | Acts as a component of the outer kinetochore KNL1 complex that serves as a docking point for spindle assembly checkpoint components and mediates microtubule-kinetochore interactions. |
| METTL5 | rRNA N(6)-adenosine-methyltransferase METTL5 | Catalytic subunit of a heterodimer with TRMT112, which specifically methylates the 6th position of adenine in position 1832 of 18S rRNA. |
| SASS6 | Spindle assembly abnormal protein 6 homolog | Central scaffolding component of the centrioles ensuring their 9-fold symmetry. |
| TRAPPC14 | Trafficking protein particle complex subunit 14 | Specific subunit of the TRAPP (transport protein particle) II complex, a highly conserved vesicle tethering complex that functions in late Golgi trafficking as a membrane tether. |
| CEP63 | Centrosomal protein of 63 kDa | Required for normal spindle assembly. |
| MFSD2A | Sodium-dependent lysophosphatidylcholine symporter 1 | Sodium-dependent lysophosphatidylcholine (LPC) symporter, which plays an essential role for blood-brain barrier formation and function. |
| NCAPD3 | Condensin-2 complex subunit D3 | Regulatory subunit of the condensin-2 complex, a complex which establishes mitotic chromosome architecture and is involved in physical rigidity of the chromatid axis. |
| CEP135 | Centrosomal protein of 135 kDa | Centrosomal microtubule-binding protein involved in centriole biogenesis. |
| ANKLE2 | Ankyrin repeat and LEM domain-containing protein 2 | Involved in mitotic nuclear envelope reassembly by promoting dephosphorylation of BAF/BANF1 during mitotic exit. |
| CEP152 | Centrosomal protein of 152 kDa | Necessary for centrosome duplication; the function also seems to involve CEP63, CDK5RAP2 and WDR62 through a stepwise assembled complex at the centrosome that recruits CDK2 required for centriole duplication. |
| PYCR2 | Pyrroline-5-carboxylate reductase 2 | Oxidoreductase that catalyzes the last step in proline biosynthesis, which corresponds to the reduction of pyrroline-5-carboxylate to L-proline using NAD(P)H. |
| PHC1 | Polyhomeotic-like protein 1 | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. |
| ZNF335 | Zinc finger protein 335 | Component or associated component of some histone methyltransferase complexes may regulate transcription through recruitment of those complexes on gene promoters. |
| ANGPT2 | Angiopoietin-2 | Binds to TEK/TIE2, competing for the ANGPT1 binding site, and modulating ANGPT1 signaling. |
Protein-family classification
Druggable: 4 · Difficult: 5 · Unknown: 18 · Druggable fraction: 0.15
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Transporter | 1 | 2.9× | 0.442 |
| Kinase | 2 | 2.0× | 0.442 |
| Scaffold/PPI | 3 | 1.9× | 0.442 |
| Other/Unknown | 18 | 1.2× | 0.442 |
| Antibody/Immunoglobulin | 1 | 1.1× | 0.732 |
| Transcription factor | 2 | 0.6× | 0.856 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| TAF13 | Other/Unknown | no | TFIID_TAF13, Histone-fold | |
| CPAP | Other/Unknown | no | CENPJ_C_dom, TCP10L/CENPJ, Tcp10_C_sf | |
| ASPM | Antibody/Immunoglobulin | yes | IQ_motif_EF-hand-BS, CH_dom, ARM-like | |
| CIT | Kinase | yes | Prot_kinase_dom, AGC-kinase_C, CNH_dom | |
| WDR62 | Scaffold/PPI | no | WD40_rpt, Quinoprotein_ADH-like_sf, WD40/YVTN_repeat-like_dom_sf | |
| MCPH1 | Other/Unknown | no | BRCT_dom, Microcephalin-like, Microcephalin_mammal | |
| STIL | Other/Unknown | no | STIL, STIL_CC, STIL_N | |
| CDK6 | Kinase | yes | 2.7.11.22 | Prot_kinase_dom, Ser/Thr_kinase_AS, Kinase-like_dom_sf |
| CDK5RAP2 | Other/Unknown | no | Cnn_1N, CDK5RAP2, CDK5RAP2_MYOME_CC | |
| KIF14 | Other/Unknown | no | FHA_dom, Kinesin_motor_dom, SMAD_FHA_dom_sf | |
| TEDC1 | Other/Unknown | no | TEDC1_dom, TEDC1 | |
| COPB2 | Scaffold/PPI | no | WD40_rpt, Beta-prop_COPA/B_2nd, WD40/YVTN_repeat-like_dom_sf | |
| KNL1 | Other/Unknown | no | Blinkin, Knl1_RWD_C, KNL1_MELT_rpt | |
| METTL5 | Other/Unknown | no | DNA_methylase_N6_adenine_CS, Small_mtfrase_dom, SAM-dependent_MTases_sf | |
| SASS6 | Other/Unknown | no | SAS-6_N, SAS-6_N_sf, SAS6_CC | |
| TRAPPC14 | Other/Unknown | no | TRAPPC14, TRAPP14_C, TRAPP14_N | |
| CEP63 | Other/Unknown | no | CEP63/Deup1_N, CEP63/Deup1_CC | |
| MFSD2A | Transporter | yes | MFS_trans_sf, MFS_2 | |
| NCAPD3 | Other/Unknown | no | ARM-like, NCAPD3, ARM-type_fold | |
| CEP135 | Other/Unknown | no | Centriole_BasalBody_StrucProt | |
| ANKLE2 | Scaffold/PPI | no | Ankyrin_rpt, LEM_dom, LEM/LEM-like_dom_sf | |
| CEP152 | Other/Unknown | no | CEP152/SHC-Transforming, CEP152_CC, CEP152_PLK4_bind | |
| PYCR2 | Other/Unknown | no | Pyrroline-COOH_reductase, 6-PGluconate_DH-like_C_sf, P5C_Rdtase_cat_N | |
| PHC1 | Transcription factor | no | SAM, Znf_FCS, SAM/pointed_sf | |
| ZNF335 | Transcription factor | no | Znf_C2H2_type, Znf_C2H2_sf, Zinc_finger/UBP_domain | |
| ANGPT2 | Other/Unknown | no | Fibrinogen_a/b/g_C_dom, Fibrinogen_a/b/g_C_1, Fibrinogen_CS | |
| MCPH1-AS1 | Other/Unknown | no |
Expression context
Cohort genes with no expression data: 0.
24 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 27 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| secondary oocyte | 8 |
| oocyte | 5 |
| ventricular zone | 4 |
| sperm | 3 |
| sural nerve | 3 |
| right testis | 3 |
| granulocyte | 3 |
| lateral nuclear group of thalamus | 2 |
| left testis | 2 |
| calcaneal tendon | 2 |
| primordial germ cell in gonad | 2 |
| trabecular bone tissue | 2 |
| mucosa of transverse colon | 2 |
| tendon of biceps brachii | 2 |
| parotid gland | 2 |
| stromal cell of endometrium | 2 |
| male germ line stem cell (sensu Vertebrata) in testis | 2 |
| buccal mucosa cell | 2 |
| right uterine tube | 2 |
| gingival epithelium | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| TAF13 | 270 | ubiquitous | marker | medial globus pallidus, lateral nuclear group of thalamus, gingival epithelium |
| CPAP | 246 | ubiquitous | marker | sperm, left lobe of thyroid gland, right lobe of thyroid gland |
| ASPM | 176 | ubiquitous | marker | oocyte, ventricular zone, secondary oocyte |
| CIT | 232 | ubiquitous | marker | lateral nuclear group of thalamus, right frontal lobe, sural nerve |
| WDR62 | 211 | ubiquitous | marker | left testis, right testis, testis |
| MCPH1 | 204 | ubiquitous | marker | secondary oocyte, ganglionic eminence, calcaneal tendon |
| STIL | 221 | ubiquitous | marker | secondary oocyte, oocyte, primordial germ cell in gonad |
| CDK6 | 262 | ubiquitous | marker | adrenal tissue, trabecular bone tissue, pylorus |
| CDK5RAP2 | 272 | ubiquitous | marker | sural nerve, ventricular zone, right coronary artery |
| KIF14 | 144 | ubiquitous | marker | secondary oocyte, endometrium epithelium, trabecular bone tissue |
| TEDC1 | 169 | ubiquitous | yes | tendon of biceps brachii, granulocyte, mucosa of transverse colon |
| COPB2 | 295 | ubiquitous | marker | parotid gland, stromal cell of endometrium, type B pancreatic cell |
| KNL1 | 193 | ubiquitous | marker | male germ line stem cell (sensu Vertebrata) in testis, ventricular zone, primordial germ cell in gonad |
| METTL5 | 292 | ubiquitous | marker | parotid gland, skeletal muscle tissue of biceps brachii, biceps brachii |
| SASS6 | 178 | ubiquitous | marker | oocyte, secondary oocyte, male germ line stem cell (sensu Vertebrata) in testis |
| TRAPPC14 | 262 | ubiquitous | yes | mucosa of transverse colon, granulocyte, right testis |
| CEP63 | 282 | ubiquitous | marker | calcaneal tendon, colonic epithelium, cortical plate |
| MFSD2A | 220 | ubiquitous | marker | right lobe of liver, skin of abdomen, ileal mucosa |
| NCAPD3 | 226 | ubiquitous | marker | sural nerve, secondary oocyte, ventricular zone |
| CEP135 | 238 | ubiquitous | marker | amniotic fluid, buccal mucosa cell, sperm |
| ANKLE2 | 289 | ubiquitous | marker | stromal cell of endometrium, left testis, right testis |
| CEP152 | 218 | ubiquitous | marker | secondary oocyte, oocyte, sperm |
| PYCR2 | 251 | ubiquitous | marker | cardiac muscle of right atrium, right uterine tube, left ventricle myocardium |
| PHC1 | 252 | ubiquitous | marker | right uterine tube, adenohypophysis, pituitary gland |
| ZNF335 | 199 | ubiquitous | marker | granulocyte, right hemisphere of cerebellum, cerebellar hemisphere |
| ANGPT2 | 219 | broad | marker | tendon of biceps brachii, popliteal artery, tibial artery |
| MCPH1-AS1 | 167 | ubiquitous | yes | buccal mucosa cell, oocyte, secondary oocyte |
Protein interactions among cohort
Intra-cohort edges: 79.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| KIF14 | 6,868 |
| CDK6 | 6,767 |
| CIT | 5,077 |
| KNL1 | 3,438 |
| COPB2 | 2,982 |
| ASPM | 2,949 |
| SASS6 | 2,336 |
| CPAP | 2,242 |
| CEP135 | 2,226 |
| NCAPD3 | 2,202 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| ANKLE2 | CEP135 | string_interaction |
| ANKLE2 | CEP152 | string_interaction |
| ANKLE2 | CPAP | string_interaction |
| ANKLE2 | MCPH1 | string_interaction |
| ANKLE2 | MFSD2A | string_interaction |
| ANKLE2 | SASS6 | string_interaction |
| ANKLE2 | TRAPPC14 | string_interaction |
| ANKLE2 | WDR62 | string_interaction |
| ANKLE2 | ZNF335 | string_interaction |
| ASPM | CDK5RAP2 | string_interaction |
| ASPM | CEP152 | string_interaction |
| ASPM | CEP63 | string_interaction |
| ASPM | CIT | string_interaction |
| ASPM | CPAP | string_interaction |
| ASPM | KIF14 | string_interaction |
| ASPM | MCPH1 | string_interaction |
| ASPM | STIL | string_interaction |
| ASPM | WDR62 | string_interaction |
| ASPM | ZNF335 | string_interaction |
| CDK5RAP2 | CEP135 | string_interaction |
| CDK5RAP2 | CEP152 | biogrid_interaction, intact, string_interaction |
| CDK5RAP2 | CEP63 | string_interaction |
| CDK5RAP2 | CPAP | string_interaction |
| CDK5RAP2 | MCPH1 | string_interaction |
| CDK5RAP2 | STIL | string_interaction |
| CDK5RAP2 | WDR62 | string_interaction |
| CDK5RAP2 | ZNF335 | string_interaction |
| CDK6 | ZNF335 | intact |
| CEP135 | CEP152 | string_interaction |
| CEP135 | CEP63 | string_interaction |
| CEP135 | CPAP | intact, string_interaction |
| CEP135 | MCPH1 | string_interaction |
| CEP135 | MFSD2A | string_interaction |
| CEP135 | SASS6 | intact, string_interaction |
| CEP135 | STIL | string_interaction |
| CEP135 | WDR62 | string_interaction |
| CEP135 | ZNF335 | string_interaction |
| CEP152 | CEP63 | biogrid_interaction, string_interaction |
| CEP152 | CPAP | string_interaction |
| CEP152 | MCPH1 | string_interaction |
| CEP152 | SASS6 | biogrid_interaction, string_interaction |
| CEP152 | STIL | string_interaction |
| CEP152 | TRAPPC14 | string_interaction |
| CEP152 | WDR62 | intact, string_interaction |
| CEP152 | ZNF335 | string_interaction |
| CEP63 | CPAP | string_interaction |
| CEP63 | SASS6 | string_interaction |
| CEP63 | STIL | string_interaction |
| CEP63 | WDR62 | string_interaction |
| CIT | KIF14 | string_interaction |
Structural data
PDB: 18 · AlphaFold-only: 8 · No structure: 1
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| TAF13 | Q15543 | 28 |
| CDK6 | Q00534 | 22 |
| MCPH1 | Q8NEM0 | 9 |
| KNL1 | Q8NG31 | 7 |
| ANGPT2 | O15123 | 7 |
| CPAP | Q9HC77 | 6 |
| STIL | Q15468 | 5 |
| CDK5RAP2 | Q96SN8 | 4 |
| METTL5 | Q9NRN9 | 3 |
| CEP63 | Q96MT8 | 3 |
| CEP152 | O94986 | 3 |
| COPB2 | P35606 | 2 |
| SASS6 | Q6UVJ0 | 2 |
| CEP135 | Q66GS9 | 2 |
| PYCR2 | Q96C36 | 2 |
| MFSD2A | Q8NA29 | 1 |
| NCAPD3 | P42695 | 1 |
| PHC1 | P78364 | 1 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| TRAPPC14 | Q8WVR3 | 71.53 |
| CIT | O14578 | 69.75 |
| KIF14 | Q15058 | 65.68 |
| ANKLE2 | Q86XL3 | 65.14 |
| TEDC1 | Q86SX3 | 63.08 |
| WDR62 | O43379 | 61.19 |
| ZNF335 | Q9H4Z2 | 52.13 |
| ASPM | Q8IZT6 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 108. Enrichment computed across 27 evidence-associated genes (19 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 19 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Loss of Nlp from mitotic centrosomes | 5 | 41.7× | 4e-06 | CPAP, CDK5RAP2, CEP63, CEP135, CEP152 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 5 | 41.7× | 4e-06 | CPAP, CDK5RAP2, CEP63, CEP135, CEP152 |
| AURKA Activation by TPX2 | 5 | 40.1× | 4e-06 | CPAP, CDK5RAP2, CEP63, CEP135, CEP152 |
| Recruitment of mitotic centrosome proteins and complexes | 5 | 35.8× | 6e-06 | CPAP, CDK5RAP2, CEP63, CEP135, CEP152 |
| Regulation of PLK1 Activity at G2/M Transition | 5 | 33.4× | 6e-06 | CPAP, CDK5RAP2, CEP63, CEP135, CEP152 |
| Recruitment of NuMA to mitotic centrosomes | 5 | 30.7× | 8e-06 | CPAP, CDK5RAP2, CEP63, CEP135, CEP152 |
| Anchoring of the basal body to the plasma membrane | 5 | 29.8× | 8e-06 | CPAP, CDK5RAP2, CEP63, CEP135, CEP152 |
| Cell Cycle, Mitotic | 6 | 15.2× | 2e-05 | MCPH1, CDK6, KNL1, CEP63, ANKLE2, CEP152 |
| M Phase | 5 | 17.4× | 9e-05 | MCPH1, KNL1, CEP63, ANKLE2, CEP152 |
| Cell Cycle | 6 | 11.4× | 9e-05 | MCPH1, CDK6, KNL1, CEP63, ANKLE2, CEP152 |
| RHO GTPases activate CIT | 2 | 63.3× | 0.004 | CIT, KIF14 |
| Centrosome maturation | 2 | 26.7× | 0.021 | CEP63, CEP152 |
| Mitotic Prometaphase | 3 | 10.9× | 0.021 | KNL1, CEP63, CEP152 |
| Diseases of Cellular Senescence | 1 | 200.3× | 0.028 | CDK6 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | 1 | 200.3× | 0.028 | CDK6 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | 1 | 200.3× | 0.028 | CDK6 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | 1 | 200.3× | 0.028 | CDK6 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | 1 | 200.3× | 0.028 | CDK6 |
| Diseases of cellular response to stress | 1 | 200.3× | 0.028 | CDK6 |
| Condensation of Prophase Chromosomes | 2 | 16.5× | 0.035 | MCPH1, NCAPD3 |
| Drug-mediated inhibition of CDK4/CDK6 activity | 1 | 120.2× | 0.043 | CDK6 |
| Mitotic G2-G2/M phases | 2 | 13.4× | 0.045 | CEP63, CEP152 |
| G2/M Transition | 2 | 13.4× | 0.045 | CEP63, CEP152 |
| Cilium Assembly | 2 | 11.4× | 0.058 | CEP63, CEP152 |
| Mitotic Metaphase and Anaphase | 2 | 10.2× | 0.067 | KNL1, ANKLE2 |
| Mitotic Anaphase | 2 | 10.2× | 0.067 | KNL1, ANKLE2 |
| Signaling by Rho GTPases | 3 | 5.4× | 0.068 | KIF14, KNL1, ANKLE2 |
| Oxidative Stress Induced Senescence | 2 | 9.5× | 0.068 | CDK6, PHC1 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 3 | 5.3× | 0.068 | KIF14, KNL1, ANKLE2 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 1 | 46.2× | 0.077 | CDK6 |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 26 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| centriole replication | 7 | 197.3× | 5e-13 | CPAP, WDR62, CDK5RAP2, SASS6, CEP63, CEP135, CEP152 |
| positive regulation of centriole replication | 3 | 388.9× | 4e-06 | CPAP, STIL, SASS6 |
| positive regulation of spindle assembly | 3 | 243.1× | 1e-05 | CPAP, STIL, SASS6 |
| cell division | 7 | 12.4× | 6e-05 | CPAP, CDK6, KIF14, KNL1, CEP63, NCAPD3, ANKLE2 |
| centrosome duplication | 3 | 108.0× | 1e-04 | STIL, SASS6, CEP152 |
| regulation of mitotic spindle organization | 3 | 97.2× | 1e-04 | CPAP, STIL, SASS6 |
| cerebral cortex development | 4 | 31.6× | 2e-04 | ASPM, WDR62, MCPH1, KIF14 |
| positive regulation of neuroblast proliferation | 3 | 67.0× | 3e-04 | ASPM, WDR62, ZNF335 |
| de novo centriole assembly involved in multi-ciliated epithelial cell differentiation | 2 | 259.3× | 6e-04 | CEP63, CEP152 |
| positive regulation of establishment of protein localization | 2 | 216.1× | 8e-04 | CPAP, CEP135 |
| positive regulation of G1/S transition of mitotic cell cycle | 3 | 46.3× | 8e-04 | CPAP, STIL, SASS6 |
| regulation of mitotic cell cycle spindle assembly checkpoint | 2 | 162.0× | 0.001 | CDK5RAP2, KNL1 |
| regulation of centrosome cycle | 2 | 144.0× | 0.001 | WDR62, MCPH1 |
| positive regulation of non-motile cilium assembly | 2 | 144.0× | 0.001 | CPAP, CEP135 |
| regulation of centriole replication | 2 | 129.6× | 0.002 | CPAP, STIL |
| generation of neurons | 2 | 117.8× | 0.002 | CIT, CDK6 |
| microtubule organizing center organization | 2 | 108.0× | 0.002 | STIL, CDK5RAP2 |
| regulation of G2/M transition of mitotic cell cycle | 2 | 99.7× | 0.002 | CDK6, KIF14 |
| regulation of neuron differentiation | 2 | 56.4× | 0.007 | WDR62, CDK5RAP2 |
| protein localization to centrosome | 2 | 51.9× | 0.007 | MCPH1, STIL |
| neuronal stem cell population maintenance | 2 | 51.9× | 0.007 | ASPM, MCPH1 |
| cerebellar granular layer structural organization | 1 | 648.1× | 0.012 | KIF14 |
| astral microtubule nucleation | 1 | 648.1× | 0.012 | CPAP |
| negative regulation of asymmetric cell division | 1 | 648.1× | 0.012 | ASPM |
| negative regulation of positive chemotaxis | 1 | 648.1× | 0.012 | ANGPT2 |
| lysophospholipid translocation | 1 | 648.1× | 0.012 | MFSD2A |
| regulation of phosphatidylethanolamine metabolic process | 1 | 648.1× | 0.012 | MFSD2A |
| obsolete regulation of phosphatidylserine metabolic process | 1 | 648.1× | 0.012 | MFSD2A |
| regulation of cell maturation | 1 | 648.1× | 0.012 | KIF14 |
| positive regulation of meiosis I spindle assembly checkpoint | 1 | 648.1× | 0.012 | KNL1 |
Therapeutics
Drug target analysis
Approved (phase 4): 2 · Phase ≥3: 2 · Phased (≥1): 3 · Undrugged: 24
Druggability breadth: 8 of 27 evidence-associated genes (30%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Genes with an approved drug
The molecule shown is one approved compound that hits the gene — not necessarily a drug of choice or one indicated for this disease.
| Symbol | Example approved molecule |
|---|---|
| CIT | MOMELOTINIB |
| CDK6 | PALBOCICLIB |
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| CDK6 | 45 | 4 |
| CIT | 41 | 4 |
| NCAPD3 | 1 | 2 |
| TAF13 | 0 | 0 |
| CPAP | 0 | 0 |
| ASPM | 0 | 0 |
| WDR62 | 0 | 0 |
| MCPH1 | 0 | 0 |
| STIL | 0 | 0 |
| CDK5RAP2 | 0 | 0 |
Drugs targeting cohort genes (top 30)
| Molecule | Max phase | Targets in cohort |
|---|---|---|
| MOMELOTINIB | 4 | CDK6, CIT |
| AFATINIB | 4 | CIT |
| FEDRATINIB | 4 | CIT |
| SORAFENIB | 4 | CDK6, CIT |
| RUXOLITINIB | 4 | CIT |
| BARICITINIB | 4 | CIT |
| VANDETANIB | 4 | CIT |
| BOSUTINIB | 4 | CIT |
| ABEMACICLIB | 4 | CDK6, CIT |
| GILTERITINIB | 4 | CIT |
| SUNITINIB | 4 | CIT |
| ERLOTINIB | 4 | CIT |
| GEFITINIB | 4 | CIT |
| PALBOCICLIB | 4 | CDK6 |
| RIBOCICLIB | 4 | CDK6 |
| TRILACICLIB | 4 | CDK6 |
| DABRAFENIB | 4 | CDK6 |
| OLAPARIB | 4 | CDK6 |
| VATALANIB | 3 | CIT |
| AFURESERTIB | 3 | CIT |
| CANERTINIB | 3 | CIT |
| FASUDIL | 3 | CIT |
| ALVOCIDIB | 3 | CDK6, CIT |
| DOVITINIB | 3 | CDK6, CIT |
| MOTESANIB | 3 | CIT |
| LESTAURTINIB | 3 | CDK6, CIT |
| RUBOXISTAURIN | 3 | CIT |
| LEROCICLIB | 3 | CDK6 |
| DINACICLIB | 3 | CDK6 |
| DALPICICLIB | 3 | CDK6 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 1.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| CDK6 | 715 | Binding:691, Functional:24 |
| CIT | 145 | Binding:145 |
| NCAPD3 | 6 | Binding:6 |
| PYCR2 | 2 | Binding:2 |
| KIF14 | 1 | Binding:1 |
| COPB2 | 1 | Binding:1 |
| METTL5 | 1 | Binding:1 |
Cohort enzymes (BRENDA EC)
| Symbol | EC numbers | Names |
|---|---|---|
| CDK6 | 2.7.11.22 | cyclin-dependent kinase |
Cohort genes with high screening signal
≥100 ChEMBL assays — a studied-ness signal; see Therapeutics for approved-drug status.
| Symbol | ChEMBL assays |
|---|---|
| CIT | 145 |
| CDK6 | 715 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 26; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
30 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
| Compound | Max phase | Cohort target (bioactivity) |
|---|---|---|
| MOMELOTINIB | 4 | CDK6, CIT |
| AFATINIB | 4 | CIT |
| FEDRATINIB | 4 | CIT |
| SORAFENIB | 4 | CDK6, CIT |
| RUXOLITINIB | 4 | CIT |
| BARICITINIB | 4 | CIT |
| VANDETANIB | 4 | CIT |
| BOSUTINIB | 4 | CIT |
| ABEMACICLIB | 4 | CDK6, CIT |
| GILTERITINIB | 4 | CIT |
| SUNITINIB | 4 | CIT |
| ERLOTINIB | 4 | CIT |
| GEFITINIB | 4 | CIT |
| PALBOCICLIB | 4 | CDK6 |
| RIBOCICLIB | 4 | CDK6 |
| TRILACICLIB | 4 | CDK6 |
| DABRAFENIB | 4 | CDK6 |
| OLAPARIB | 4 | CDK6 |
| VATALANIB | 3 | CIT |
| AFURESERTIB | 3 | CIT |
| CANERTINIB | 3 | CIT |
| FASUDIL | 3 | CIT |
| ALVOCIDIB | 3 | CDK6, CIT |
| DOVITINIB | 3 | CDK6, CIT |
| MOTESANIB | 3 | CIT |
| LESTAURTINIB | 3 | CDK6, CIT |
| RUBOXISTAURIN | 3 | CIT |
| LEROCICLIB | 3 | CDK6 |
| DINACICLIB | 3 | CDK6 |
| DALPICICLIB | 3 | CDK6 |
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 2 | CIT, CDK6 |
| B | Phased (≥1) drug, not yet approved | 1 | NCAPD3 |
| C | Druggable family + PDB, no drug | 1 | MFSD2A |
| D | Druggable family + AlphaFold only, no drug | 1 | ASPM |
| E | Difficult family or no structure, no drug | 22 | TAF13, CPAP, WDR62, MCPH1, STIL, CDK5RAP2, KIF14, TEDC1, COPB2, KNL1 (+12 more) |
Undrugged target profiles
24 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| KIF14 | 1 | CIT |
| TAF13 | 0 | — |
| CPAP | 0 | — |
| ASPM | 0 | — |
| WDR62 | 0 | — |
| MCPH1 | 0 | — |
| STIL | 0 | — |
| CDK5RAP2 | 0 | — |
| TEDC1 | 0 | — |
| COPB2 | 1 | — |
| KNL1 | 0 | — |
| METTL5 | 1 | — |
| SASS6 | 0 | — |
| TRAPPC14 | 0 | — |
| CEP63 | 0 | — |
| MFSD2A | 0 | — |
| CEP135 | 0 | — |
| ANKLE2 | 0 | — |
| CEP152 | 0 | — |
| PYCR2 | 2 | — |
| PHC1 | 0 | — |
| ZNF335 | 0 | — |
| ANGPT2 | 0 | — |
| MCPH1-AS1 | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 0.